1. Home
  2. BIRD vs MGX Comparison

BIRD vs MGX Comparison

Compare BIRD & MGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIRD
  • MGX
  • Stock Information
  • Founded
  • BIRD 2015
  • MGX 2018
  • Country
  • BIRD United States
  • MGX United States
  • Employees
  • BIRD N/A
  • MGX N/A
  • Industry
  • BIRD Apparel
  • MGX
  • Sector
  • BIRD Consumer Discretionary
  • MGX
  • Exchange
  • BIRD Nasdaq
  • MGX NYSE
  • Market Cap
  • BIRD 87.0M
  • MGX 70.4M
  • IPO Year
  • BIRD 2021
  • MGX 2024
  • Fundamental
  • Price
  • BIRD $7.71
  • MGX $3.55
  • Analyst Decision
  • BIRD Hold
  • MGX Strong Buy
  • Analyst Count
  • BIRD 4
  • MGX 7
  • Target Price
  • BIRD $21.50
  • MGX $16.67
  • AVG Volume (30 Days)
  • BIRD 59.8K
  • MGX 4.5M
  • Earning Date
  • BIRD 11-06-2024
  • MGX 02-12-2025
  • Dividend Yield
  • BIRD N/A
  • MGX N/A
  • EPS Growth
  • BIRD N/A
  • MGX N/A
  • EPS
  • BIRD N/A
  • MGX N/A
  • Revenue
  • BIRD $205,895,000.00
  • MGX $55,080,000.00
  • Revenue This Year
  • BIRD N/A
  • MGX $11.59
  • Revenue Next Year
  • BIRD N/A
  • MGX N/A
  • P/E Ratio
  • BIRD N/A
  • MGX N/A
  • Revenue Growth
  • BIRD N/A
  • MGX 45.13
  • 52 Week Low
  • BIRD $7.25
  • MGX $1.61
  • 52 Week High
  • BIRD $29.00
  • MGX $12.74
  • Technical
  • Relative Strength Index (RSI)
  • BIRD 40.65
  • MGX 64.37
  • Support Level
  • BIRD $7.58
  • MGX $2.91
  • Resistance Level
  • BIRD $8.28
  • MGX $3.63
  • Average True Range (ATR)
  • BIRD 0.47
  • MGX 0.54
  • MACD
  • BIRD 0.07
  • MGX 0.09
  • Stochastic Oscillator
  • BIRD 17.14
  • MGX 55.66

About BIRD Allbirds Inc.

Allbirds Inc is a lifestyle brand that innovates with naturally derived materials to make footwear and apparel products in a better way, while treading lighter on the planet. Its primary source of revenue is from sales of shoes and apparel products. The majority of the revenue is derived from United States.

About MGX METAGENOMI INC

Metagenomi Inc is a genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived genome editing toolbox. Genetic diseases are caused by a diverse set of mutations that have been largely inaccessible by genome engineering approaches to date. The genome editing toolbox includes programmable nucleases, base editors, and RNA and DNA-mediated integration systems (including prime editing systems and clustered regularly interspaced short palindromic repeat (CRISPR)-associated transposases (CASTs).

Share on Social Networks: